CN Patent
CN102085194A — 左乙拉西坦口腔崩解片及其制备方法
Assigned to Beijing Yiling Bioengineering Co Ltd · Expires 2011-06-08 · 15y expired
What this patent protects
本发明提供了一种左乙拉西坦口腔崩解片及其制备方法,本发明左乙拉西坦口腔崩解片采用冷冻干燥工艺制备,其活性成分为左乙拉西坦,此外还有固体分散剂聚乙二醇6000,冻干保护剂麦芽糖糊精,粘合剂水解明胶。左乙拉西坦是一种新型抗癫痫药,本发明左乙拉西坦口腔崩解片有利于提高患者用药依从性,提高疗效。
USPTO Abstract
本发明提供了一种左乙拉西坦口腔崩解片及其制备方法,本发明左乙拉西坦口腔崩解片采用冷冻干燥工艺制备,其活性成分为左乙拉西坦,此外还有固体分散剂聚乙二醇6000,冻干保护剂麦芽糖糊精,粘合剂水解明胶。左乙拉西坦是一种新型抗癫痫药,本发明左乙拉西坦口腔崩解片有利于提高患者用药依从性,提高疗效。
Drugs covered by this patent
- Keppra (levetiracetam) · Generic (originally UCB Pharma)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.